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http://dx.doi.org/10.1016/j.stemcr.2016.11.009SUMMARYHippocalcin (HPCA) is a calcium-binding protein that is restricted to nervous tissue and contributes to neuronal activity. Here we report
that, in addition to inducing neurogenesis, HPCA inhibits astrocytic differentiation of neural stem cells. It promotes neurogenesis by
regulating protein kinase Ca (PKCa) activation by translocating to the membrane and binding to phosphoinositide-dependent protein
kinase 1 (PDK1), which induces PKCa phosphorylation. We also found that phospholipase D1 (PLD1) is implicated in the HPCA-medi-
ated neurogenesis pathway; this enzyme promotes dephosphorylation of signal transducer and activator of transcription 3 (STAT3
[Y705]), which is necessary for astrocytic differentiation. Moreover, we found that the SH2-domain-containing tyrosine phosphatase
1 (SHP-1) acts upstream of STAT3. Importantly, this SHP-1-dependent STAT3-inhibitory mechanism is closely involved in neurogenesis
and suppression of gliogenesis by HPCA. Taken together, these observations suggest that HPCA promotes neuronal differentiation
through activation of the PKCa/PLD1 cascade followed by activation of SHP-1, which dephosphorylates STAT3(Y705), leading to inhi-
bition of astrocytic differentiation.INTRODUCTION
Neural stem cells (NSCs), defined as neural precursor cells
that can self-renew, give rise to three major cell types: neu-
rons, astrocytes, and oligodendrocytes (Miller and Gauth-
ier, 2007; Qian et al., 2000). Multipotent NSCs can be iso-
lated and cultured from primary cortical or hippocampal
cultures after passage in the presence of mitogenic growth
factors (Gage et al., 1995). In cultures of rat embryonic day
14 (E14) cells, cortical NSCs give rise primarily to neurons
and dividing precursor cells; astrocytes are generated only
when cells are cultured for several days (Ghosh and Green-
berg, 1995). The molecular mechanisms by which NSCs
undergo differentiation into neurons versus astrocytes are
not well understood.
Hippocalcin (HPCA) is a high-affinity calcium-binding
protein restricted to the CNS and ismost abundant in pyra-
midal cells of the hippocampus CA1 region (Kobayashi
et al., 2012). During brain development HPCA expression
increases sharply, concurrent with synapse formation (Sai-
toh et al., 1994). HPCA belongs to the family of EF-hand-
containing neuronal calcium sensor proteins, which
possess a Ca2+/myristoyl switch that allows translocation
to membranes in response to increased cytosolic Ca2+ con-
centrations. It also regulates mixed-lineage kinase 2, phos-
pholipase D (PLD), and neuronal apoptosis inhibitory pro-
tein (Burgoyne and Weiss, 2001; Kobayashi et al., 1993;
Lindholm et al., 2002; Nagata et al., 1998; O’Callaghan
et al., 2002; O’Callaghan et al., 2003). We have reported
that HPCA is a major regulatory protein in the Ca2+-medi-
ated PLD signaling pathway (Oh et al., 2006) and that it in-Stem C
This is an open access article under the Cduces expression of Neuro-D, leading to neurite outgrowth
in H19-7 cells during differentiation (Oh et al., 2008). It is
possible that HPCA regulates neurogenesis through these
molecules; however, molecular mechanisms by which
HPCA affects neuronal/astrocyte cell-fate decision have
not been studied.
PLD is a ubiquitous enzyme that catalyzes the hydrolysis
of phosphatidylcholine (PC) to phosphatidic acid and
choline (Exton, 1997). Phosphatidic acid (PA) itself acts as
a cellular messenger or can be transformed by PA phospho-
hydrolase into diacylglycerol, which is essential for activa-
tion of protein kinase C (PKC) (Manifava et al., 2001; Zhao
et al., 2007). PKCa regulates Ca2+-dependent differentia-
tion in several cell lines and primary cells (Kopach et al.,
2013; Park et al., 2015) and plays an essential role in synap-
tic plasticity by raising intracellular Ca2+ levels in neurons
(Kopach et al., 2013). Activation and phosphorylation of
PLD1 are regulated by PKCa in phorbol myristate acetate-
treated COS-7 cells, and a similar interrelationship between
PLD and PKC isoforms is seen in a variety of cell types (Kim
et al., 2005). Recent studies have reported that PLD plays a
key role in neuronal differentiation of cells such as PC12
cells (Banno et al., 2008) and cerebellar granule neurons
(Watanabe et al., 2004). We have also reported that it has
a critical role in the neuronal differentiation of rat NSCs
(Yoon et al., 2005) andH19-7 cells (Yoon et al., 2012). How-
ever, the relevance of PLD1 signaling in neuronal differen-
tiation remains unclear.
The signal transducer and activator of transcription
(STAT) family participates in the regulation of genes
involved in the acute phase of inflammatory response,ell Reports j Vol. 8 j 95–111 j January 10, 2017 j ª 2017 The Authors. 95
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cell growth, and cell differentiation (Park et al., 2010).
Among them, STAT3 is an important transcription factor
for the regulation of glial fibrillary acidic protein (GFAP)
expression, and the DNA binding of STAT3 was shown to
be affected by phosphorylation of the Ser727 or/and
Tyr705 site (Yokogami et al., 2000). STAT3 binds to
different domains of CBP/p300, and the STAT/p300/Smad
complex, acting at the STAT-binding element in the
astrocyte-specific GFAP promoter, is particularly effective
at inducing astrocyte differentiation in NSCs (Nakashima
et al., 1999). Moreover, STAT3 signaling is upregulated in
certain neurodegenerative diseases (Shibata et al., 2009),
and in vitro suppression of Stat3 or its conditional deletion
in vivo promoted neurogenesis and inhibited astroglio-
genesis (Cao et al., 2010; Gu et al., 2005). Thus, STAT3 is
considered an attractive target for promoting neurogenesis.
In our previous study, STAT3 activation is associated with
PLD2 through the S6K1-ERK pathway in lipopolysaccha-
ride (LPS)-induced inflammation mechanism (Park et al.,
2010), but the relationship between PLD1 signaling and
STAT3 function is not yet defined. Thus, the present study
showed that PLD1 is required for HPCA-mediated STAT3
activation of neuronal differentiation. In addition, a num-
ber of protein tyrosine phosphatases negatively regulate
STAT3 signaling through direct dephosphorylation of
p-STAT3(Y705); these include members of the SH2-
domain-containing tyrosine phosphatase family (SHP-1
and SHP-2) and protein tyrosine phosphatase 1B (PTP-1B)
(Han et al., 2006). More specifically, SHP-1 regulates
STAT3(Y705) phosphorylation in Huh-7 HCC, PLC5, and
HepG2 cells (Chen et al., 2012). Thus, activity of SHP-1
may be critical for regulating STAT3 phosphorylation in
neuronal differentiation.
In this study, we aimed to clarify the role of HPCA in the
neuronal differentiation of NSCs. Our findings indicate
that HPCA is essential for neurogenesis of NSCs, and that
it promotes neuronal differentiation and inhibits astrocytic
differentiation.RESULTS
HPCA Is Required for Neuronal Differentiation in
NSCs
Many studies of the neurogenic-to-gliogenic switch have
focused on the developing neocortex (Qian et al., 2000;
Shen et al., 2006). We show here that HPCA is expressed
in the cerebral neocortex of the E14 rat brain (Figure 1A)
and examine its possible role in neuronal differentiation
using cortical NSCs. During growth of these cells, basic
fibroblast growth factor (bFGF) was present to prevent dif-
ferentiation and promote proliferation. To investigate the
role of HPCA in neuronal differentiation, we removed96 Stem Cell Reports j Vol. 8 j 95–111 j January 10, 2017bFGF for 24 hr. As shown in Figure 1B, mRNA expression
of Hpca and the protein level of HPCA were markedly
increased under differentiation conditions. Nerve growth
factors such as NT-3, NT4/5, and BDNF, together with the
basic helix-loop-helix transcription factors Neuro-D and
neurogenin-1 (NGN1), are closely associatedwith neuronal
differentiation and can be used as markers of this process
(Markus et al., 2002; Shin-young et al., 2007). Therefore,
we generatedNSCs that overexpressedHpca andmonitored
the levels of neuronal differentiation markers. As shown in
Figures 1C and 1D, the expression levels of Nt3, Nt4/5,
Bdnf, Neuro-D, and Ngn1 were significantly enhanced by
Hpca overexpression compared with the vector control in
the absence of bFGF. NSCs are considered as the primary
progenitor cells for neuronal and glial cell lineages during
development (Rietze et al., 2001). We examined the effects
of HPCA on the expression of neuronal and glial markers
during neuronal differentiation. In the absence of bFGF,
Hpca overexpression resulted in markedly enhanced
expression of neuron-specific class III b-tubulin (TUJ1, a
neuronal marker), while GFAP expression was significantly
decreased by Hpca when compared with the vector control
(Figure 1E). These data suggest that HPCA promotes
neuronal differentiation and suppresses astrocyte differen-
tiation in NSCs.
We reported previously that HPCA leads to neurite
outgrowth of H19-7 cells (Oh et al., 2008). To confirm its
role in neurite outgrowth in NSCs, we exposed cells to
EGFP-taggedHpca for 2 days. After 3 days of differentiation,
neurite outgrowth was measured under a fluorescence
microscope (EGFP-transfected cells fluoresce green, TUJ1-
stained cells fluoresce red, and cells transfected with both
EGFP and TUJ1 fluoresce yellow) (Figure 1F). Neurons and
astrocytes were quantified by normalizing the total num-
ber of TUJ1- and GFAP-positive cells to the total number
of DAPI-labeled cell nuclei. When Hpca was introduced,
neurite outgrowth (97.1 ± 8.3 mm versus 135.2 ± 14.1 mm,
p < 0.05, Figure 1G) and the number of TUJ1-positive cells
(43.2% ± 5.5% versus 64.1% ± 9.9%, p < 0.05, Figure 1H)
were enhanced, indicating that HPCA plays an important
role in NSC neurite outgrowth.
PKCa Is Involved in HPCA-Mediated Expression of
TUJ1 in NSCs
HPCA is aCa2+-binding protein in the neuronal Ca2+ sensor
family of proteins, which possess a Ca2+/myristoyl switch
that allows translocation to membranes in response to
increased cytosolic Ca2+ levels (Palmer et al., 2005).
Therefore, we analyzed intracellular Ca2+ mobilization in
fluo-3-loaded NSCs. When the cells were induced to differ-
entiate by removal of bFGF, intracellular Ca2+ levels
increased (Figures 2A and 2B). We also observed transloca-
tion of HPCA from the cytosol to the membrane after
Figure 1. Effect of HPCA Expression during Neuronal Differentiation of NSCs
(A) HPCA immunostaining of coronal sections of E14 rat brain cortex. The boxed area is magnified. Scale bar, 20 mm.
(B) Neuronal differentiation was induced by removal of bFGF for 1 day, and Hpca mRNA expression was analyzed by RT-PCR. Twenty
micrograms of protein was analyzed by western blotting with anti-HPCA and anti-b-ACTIN.
(C and D) NSCs were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc for 48 hr and allowed to differentiate for 24 hr.
mRNA levels of neuronal factors were analyzed by RT-PCR (C) and real-time RT-PCR (D). *p < 0.05 compared with thebFGF/vector control
(mean ± SD; n = 3).
(E) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc for 48 hr and induced to differentiate for 24 hr. Levels of
TUJ1, GFAP, MYC, and b-ACTIN were determined by western blot. *p < 0.05 compared with the bFGF/vector control (mean ± SD; n = 3).
(F) Cells were transduced with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc and induced to differentiate by withdrawal of bFGF. After
3 days, GFP-positive cells were examined by fluorescence microscopy and stained with anti-EGFP (green) and anti-TUJ1 (red). Scale bar,
20 mm.
(G and H) Neurite lengths were measured and the proportions of TUJ1-positive cells and total cells were determined in randomly selected
areas from at least three slides of each condition. *p < 0.05 compared with the bFGF/vector control (mean ± SD; n = 3).bFGF removal (Figure 2C), suggesting that binding of
Ca2+ to HPCA induces a conformational change that pro-
motes membrane association.
To confirm that increased Ca2+ levels represent intracel-
lular Ca2+, we pretreated cells with EGTA, an extracellular
Ca2+chelator, before inducing differentiation. The EGTA
had no effect on neurite outgrowth (Figure 2D) or TUJ1-
positive cells (Figure 2E), indicating that HPCA is respon-
sible for the locational changes induced by the increase
of intracellular Ca2+. HPCAhas three putative Ca2+-binding
domains of the EF-hand structure and a possible NH2-
terminal myristoylation site, which is referred to as a‘‘calcium/myristoyl switch’’ and considered to be primarily
a mechanism by which the protein can be translocated
from the cytosol to themembrane. Both structural features
are known to regulate the intracellular Ca2+-dependent
activation of HPCA. To determine whether Ca2+ binding
is required for the expressions of HPCA-mediated nerve
growth factors, we constructed Hip1-72 (N-terminal
domain without all three functional EF hands [EF2–4])
and Hip65-193 (calcium-binding domain without myristoy-
lation motif) deletion mutants using the pMSCV-IRES-
EGFP-Hpca-Myc (Figures 2F and S1). As shown in Figures
2G and 2H, Hpca-induced expression levels of Nt3, Nt4/5,Stem Cell Reports j Vol. 8 j 95–111 j January 10, 2017 97
(legend on next page)
98 Stem Cell Reports j Vol. 8 j 95–111 j January 10, 2017
Bdnf,Neuro-D, and Ngn1were significantly decreased by the
Hip1–72 (N-terminal domain) or Hip65–193 (calcium-binding
domain). This result indicated that HPCA-mediated expres-
sions of nerve growth factors are dependent on Ca2+ bind-
ing as well as the myristoylation of HPCA during neuronal
differentiation. To further investigate whether HPCA-
mediated expressions of nerve growth factors depend on
myristoylation, we made constructs with the second
glycine residue, essential for myristoylation, mutated to
an alanine (G2A) in HPCA protein. As shown in Figures
2I and 2J, G2A decreased Hpca-induced expression levels
of Nt3, Nt45, Bdnf, Neuro-D, and Ngn1 in the absence of
bFGF. This result suggests that myristoylation is essential
for expression of nerve growth factors during neuronal dif-
ferentiation of NSCs.
Interestingly, increased Ca2+ levels regulate PKCa activa-
tion and translocation to the membrane from the cytosol
in various processes (Boncoeur et al., 2013; Champion
and Kass, 2004). Therefore, we analyzed translocation of
PKCa after depleting bFGF. Translocation of PKCa from
the cytosol to the membrane occurred when neuronal
differentiation was induced (Figure 2K). In addition, the
translocation was further enhanced by overexpression of
Hpca (Figure 2K). Based on our results, we hypothesized
that Ca2+-bound HPCA binds PKCa after removal of
bFGF. To test this hypothesis, we used immunoprecipita-Figure 2. Increased Intracellular Ca2+ Affects HPCA-PKCa Activat
(A and B) NSCs were used for fluo-3/AM Ca2+ imaging 1 day after p
Procedures). We collected images every 1 s at 470 nm excitation/514
intracellular Ca2+ was defined as a 20% increase from the basal level.
(C) Cells were depleted with bFGF for 5 min, fixed, and immunostained
(D and E) Cells were pretreated with 500 mM EGTA for 1 day and incu
anti-TUJ1, TUJ1-positive cells were counted under fluorescence mic
determined in random areas from at least three slides of each cond
(p = 0.245). Scale bar, 20 mm.
(F) Schematic of Hpca (wild-type) and its deletion mutants.
(G and H) NSCs were transfected with pMSCV-IRES-EGFP, pMSCV-IRES-E
Hip65-193-Myc for 48 hr and induced to differentiate for 24 hr. mRNA le
RT-PCR (H). *p < 0.05 compared with bFGF/Hpca (mean ± SD; n = 3
(I and J) G2 is a key residue for myristoylation of HPCA. NSCs were t
pMSCV-IRES-EGFP-Hpca G2A-Myc for 48 hr and induced to differentiate
(I) and real-time RT-PCR (J). *p < 0.05 compared with bFGF/Hpca (
(K) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP
bFGF for 24 hr. Cells were then lysed and centrifuged at 100,000 3 g
(30 mg) from each fraction were analyzed by western blotting with anti
as mean ± SD (n = 3).
(L) Cells were transfected with p-MSCV-IRES-EGFP-Hpca-Myc for 48 hr,
the cell lysates with anti-MYC were analyzed by western blotting with
(M) Cells were transiently transfected with control siRNA or Hpca siRN
were analyzed by western blotting with anti-p-PKCa, anti-PKCa, anti-H
siRNA (mean ± SD; n = 3).
(N) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGF
30 min before differentiation for 1 day. Cells were lysed and analyz
anti-GAPDH. *p < 0.05 compared with bFGF/Hpca (mean ± SD; n =tion to determine whether HPCA directly binds to PKCa
during neuronal differentiation. As shown in Figure 2L,
HPCA binds to PKCa after removal of bFGF, indicating
that Ca2+-binding HPCA directly binds to PKCa. Next, to
investigate whether HPCA affects PKCa activation, we
knocked down Hpca in NSCs using Hpca siRNA. This re-
sulted in decreased phosphorylation of PKCa (Figure 2M).
To further investigate whether PKCa regulates HPCA-medi-
ated neuronal differentiation, we pretreated NSCs with the
PKCa inhibitor RO320432 for 30 min before inducing dif-
ferentiation by removing bFGF. Inhibition of PKCa mark-
edly reduced Hpca-induced expression of TUJ1, whereas
GFAP increased (Figure 2N), demonstrating that PKCa is
implicated in HPCA-mediated neuronal differentiation.
We next asked which signaling pathway was responsible
for PKCa activation during neuronal differentiation in
NSCs. PDK1 plays a central role in many signal transduc-
tion pathways by phosphorylating a site in the activation
loop of PKC isoforms and initiating their maturation (Dutil
et al., 1998; Williams et al., 2000). To determine whether
PDK1 could enhance phosphorylation of PKCa, we pre-
treated cells with the PDK1 inhibitors GSK2334470 or
BAG956 for 30 min. Inhibition of PDK1 abolished phos-
phorylation of PKCa, indicating that PDK1 regulates
PKCa activation during neuronal differentiation (Fig-
ure 3A). In addition, GSK2334470 not only decreasedion during Neuronal Differentiation of NSCs
lating on poly-L-lysine-coated glass coverslips (see Experimental
nm emission using Metafluor software. The threshold of increased
with anti-HPCA (red). The boxed area is magnified. Scale bar, 5 mm.
bated for 3 days after removal of bFGF. After immunostaining with
roscopy. The proportion of TUJ1-positive cells and total cells was
ition. Data are shown as mean ± SD (n = 3). N.S, not significant
GFP-Hpca-Myc, pMSCV-IRES-EGFP-Hip1-72-Myc, or pMSCV-IRES-EGFP-
vels of neuronal factors were analyzed by RT-PCR (G) and real-time
).
ransfected with pMSCV-IRES-EGFP, pMSCV-IRES-EGFP-Hpca-Myc, or
for 24 hr. mRNA levels of neuronal factors were analyzed by RT-PCR
mean ± SD; n = 3).
-Hpca-Myc for 48 hr and induced to differentiate by withdrawal of
to separate cytosolic and membrane fractions. Samples of protein
-PKCa, anti-MYC, anti-integrin a2, and anti-GAPDH. Data are shown
and induced differentiate for 24 hr. Immunoprecipitates (IP) from
anti-PKCa and anti-MYC.
A for 48 hr, then incubated for 1 day after removal of bFGF. Proteins
PCA, and anti-GAPDH. *p < 0.05 compared with thebFGF/control
P-Hpca-Myc for 48 hr and then treated with 10 mM RO320432 for
ed by western blotting with anti-TUJ1, anti-GFAP, anti-MYC, and
3).
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Figure 3. PDK1 Is Involved in HPCA-Mediated PKCa Activation and Neuronal Differentiation of NSCs
(A) NSCs were pretreated with 5 mM GSK2334470 or 10 mM BAG956 for 30 min before differentiation for 1 day. Cells were lysed and analyzed
by western blotting with anti-p-PKCa, anti-PKCa, anti-p-PDK1, anti-PDK1, and anti-GAPDH.
(B and C) Cells were pretreated with 5 mM GSK 2334470 and allowed to differentiate for 1 day. mRNA levels of neuronal factors were
analyzed by RT-PCR (B) and real-time RT-PCR (C). *p < 0.05 compared with the bFGF control (mean ± SD; n = 3).
(D) Cells were pretreated with 5 mM GSK2334470 and induced to differentiate by withdrawal of bFGF. After differentiation for 3 days, fixed
cells were immunostained with anti-TUJ1 (green) and anti-GFAP (red). Scale bar, 20 mm.
(E and F) Neurite lengths were measured and the numbers of TUJ1-positive cells and total cells were determined in randomly selected areas
from at least three slides of each condition. *p < 0.05 compared with the bFGF control (mean ± SD; n = 3).
(G) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc for 48 hr, and induced to differentiate for 24 hr.
Immunoprecipitates from the cell lysates with anti-PDK1 were analyzed by western blotting with anti-p-PKCa, anti-PKCa, anti-PDK1, and
anti-MYC.transcripts of Nt3, Nt4/5, Bdnf, and Neuro-D (Figures 3B
and 3C) but also significantly reduced neurite length (125
± 14.3 mm versus 45.3 ± 3.3 mm, p < 0.05, Figures 3D and
3E) and the number of TUJ1-positive cells (47.2% ± 10%
versus 18.5% ± 4%, p < 0.05, Figure 3F) when compared
with removal of bFGF. Taken together, these results demon-
strate that PDK1 signals upstream of PKCa trigger neurite
outgrowth, leading to expression of neuronal factors in
NSCs. However, the mechanism by which PDK1 affects
HPCA-mediated PKCa activation is still unknown. We hy-
pothesized that HPCA brings PKCa to PDK1, after which
PDK1 activates PKCa. To test this hypothesis, we used co-100 Stem Cell Reports j Vol. 8 j 95–111 j January 10, 2017immunoprecipitation to determine whether HPCA con-
tributes to binding between PDK1 and PKCa. HPCA stimu-
lated this binding and promoted PKCa activation (Fig-
ure 3G), supporting the idea that HPCA induces the
formation of a PDK1-PKCa complex that promotes
PKCa phosphorylation during neuronal differentiation.
Effect of PLD1 Activation on HPCA-Mediated
Neuronal Differentiation
We previously reported that PLD1 is involved in various
neuronal signaling pathways and is an important regulator
of neuron function (Yoon et al., 2006, 2012). We also
Figure 4. PLD1 Is Required for Hpca-Induced Neuronal Differentiation of NSCs
(A) Coronal sections of E14 rat brain cortex immunostained with anti-HPCA and anti-PLD1. Scale bar, 10 mm.
(B) NSCs were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc for 48 hr and labeled with 2 mCi/mL [3H]palmitic acid.
They were pretreated with 10 mM RO320432 for 30 min and allowed to differentiate for 1 day. PLD activities were determined by measuring
the formation of [3H]PBt in the presence of 1-butanol. *p < 0.05 compared with bFGF/Hpca (mean ± SD; n = 5).
(C) Cells were transfected with control siRNA or Hpca siRNA for 48 hr and then incubated for 1 day after removal of bFGF. Proteins were
analyzed by western blotting with anti-p-PLD1 (T147), anti-PLD1, anti-HPCA, and anti-b-ACTIN.
(D) Cells were transfected with control siRNA, Hpca siRNA, or Pld1 siRNA for 48 hr and induced to differentiate through withdrawal of bFGF.
After differentiation for 3 days, cells were stained for immunocytochemical analysis of neuronal (TUJ1, green) and astrocytic (GFAP, red)
markers. Scale bar, 10 mm. Graphs show the percentages of TUJ1- and GFAP-positive cells. Data are shown as mean ± SD (n = 3).
*Significantly different from bFGF/control siRNA at p < 0.05 (for TUJ1). ySignificantly different from bFGF/control siRNA at p < 0.05
(for GFAP).
(E) Cells were transfected with control siRNA, Hpca siRNA, or Pld1 siRNA for 48 hr and induced to differentiate by withdrawal of bFGF. After
differentiation for 3 days, fixed cells were immunostained with anti-TUJ1. Scale bar, 10 mm.
(F) The numbers of spines per 10-mm dendrite were counted in randomly selected areas from at least three slides of each condition. Data are
shown as mean ± SD (n = 5). *p < 0.05 compared with the bFGF/control siRNA. **p < 0.01 compared with the bFGF/control siRNA.showed that HPCA increased the activity and expression of
PLD in various cell types (Hyun et al., 2000; Oh et al.,
2006). In the present study, we found that PLD1 co-local-
ized with HPCA in the cerebral neocortex of the E14 rat
brain (Figure 4A) and therefore hypothesized that PLD1
was implicated in the HPCA-mediated neuronal differenti-
ation of NSCs. Since PLD1 is regulated by PKCa in NSCs
(Park et al., 2015), we examined whether HPCA-activated
PKCa affects PLD activation during neuronal differentia-
tion. We found that in the absence of bFGF, Hpca-inducedPLD activation was decreased by the PKCa inhibitor
RO320432 (Figure 4B). To further elucidate the role of
HPCA in PLD activation, we transfected cells with Hpca
small interfering RNA (siRNA). Knockdown of Hpca mark-
edly inhibited PLD1 phosphorylation, which is related to
PLD1 activation (Figure 4C). To determine the role of
HPCA-mediated PLD1 activation in neuronal differentia-
tion, we knocked down Hpca or Pld1 using siRNA and
found that the number of TUJ1-positive cells significantly
decreased due to knockdown of Hpca or Pld1, whereas theStem Cell Reports j Vol. 8 j 95–111 j January 10, 2017 101
Figure 5. Functional Analysis of STAT3(Y705) Activity in HPCA-Mediated Neuronal Differentiation
(A) NSCs were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc for 48 hr and induced to differentiate for 1 day.
Cell lysates were analyzed by western blotting with anti-p-STAT3(Y705), anti-p-STAT3 (S727), anti-STAT3, anti-MYC, and anti-GAPDH.
(legend continued on next page)
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number of GFAP-positive cells increased (Figure 4D). These
results suggest that HPCA-dependent PLD1 activation is
required for neuronal differentiation of NSCs.
To test whether HPCA and PLD1 promote spine forma-
tion, which implies synapse formation during neuronal
differentiation, we examined dendritic spine formation in
cells transfected with siRNA for Hpca or Pld1. Dendritic
spines were significantly decreased by knockdown of
Hpca or Pld1 (Figures 4E and 4F). Taken together, these re-
sults indicate that PLD1 plays an important role in
HPCA-mediated neuronal differentiation of NSCs.
Inhibition of STAT3(Y705) Activation Increases
Neuronal Differentiation in NSCs
The determination of neuronal/glial fate during CNS devel-
opment involves complex interactions between intrinsic
signals that act through many transcription factors (Ed-
lund and Jessell, 1999). STAT3 inhibition enhances differ-
entiation of humanNSCs tomotor neurons and reduces as-
trocytosis, and similarly induces neurogenesis and inhibits
gliogenesis (Cao et al., 2010; Natarajan et al., 2014), sup-
porting our hypothesis that STAT3 activation inhibits
neuronal differentiation and promotes astrocytic differen-
tiation. We therefore examined whether HPCA affects
STAT3 activation. Hpca was transfected into NSCs for
2 days and differentiation was induced for 1 day. As shown
in Figure 5A, Hpca increased the dephosphorylation of
p-STAT3(Y705) compared with the vector control, even in
the absence of bFGF, but did not affect p-STAT3(S727).Data are shown as mean ± SD (n = 3). *p < 0.05 compared with the +
control.
(B) Cells were transfected with control siRNA or Hpca siRNA for 48 h
western blotting with anti-p-STAT3(Y705), anti-STAT3, anti-TUJ1, a
control siRNA (mean ± SD; n = 3).
(C) Diagrams of Stat3WT (wild-type) and Stat3YF (mutant). CC, coiled-
homology 2; TA, transcriptional activation domain.
(D) Vector (pBOS-FLAG), Stat3WT, or Stat3YF were transfected into NS
Cells were lysed and analyzed by western blotting with anti-p-STAT3(
(E and F) Cells were transfected with Stat3WT or Stat3YF for 48 hr. Aft
green) and astrocytic (GFAP, red) markers. Scale bar, 10 mm. Graphs sho
as mean ± SD (n = 3). *Significantly different frombFGF/Stat3WT at
p < 0.05 (for GFAP).
(G) Neurite lengths were measured in randomly selected areas from at l
Stat3WT (mean ± SD; n = 3).
(H) Cells infected with retroviruses expressing pMSCV-IRES-EGFP or pM
or Stat3YF for 48 hr. The cells were induced to differentiate for 2 days.
are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01.
(I and J) Cells were treated as in (H) and induced to differentiate f
neuronal (TUJ1, green) and astrocytic (GFAP, red) markers. Scale bar
cells. Data are shown as mean ± SD (n = 3). *Significantly different
different from bFGF/Stat3WT/Hpca at p < 0.05 (for GFAP).
(K) Neurite lengths were measured in randomly selected areas from at l
Stat3WT/Hpca (mean ± SD; n = 3).Moreover, bFGF removal-induced p-STAT3(Y705) dephos-
phorylation and TUJ1 expression were abolished by Hpca
siRNA while GFAP expression was enhanced (Figures 5B
and S2), suggesting that Hpca-induced dephosphorylation
of p-STAT3(Y705) is crucial for the promotion of neuronal
differentiation. To further investigate whether dephos-
phorylation of p-STAT3(Y705) is essential for the neuronal
differentiation of NSCs, we prepared Stat3YFmutant (point
mutation of tyrosine 705 to phenylalanine 705). When
Stat3WT (wild-type) and Stat3YF were transfected into
HEK293 cells, respectively, STAT3 was successfully overex-
pressed (Figure S3). We validated Stat3YF mutant by
showing the disappearance of LPS-induced tyrosine phos-
phorylation of STAT3(Y705) (Figure S3). Next, we deter-
mined the effects of Stat3YF on the expression of neuronal
and glial markers during differentiation of NSCs. Stat3YF
resulted in markedly enhanced TUJ1 expression while
GFAP expression was significantly decreased by removal
of bFGF when compared with the Stat3WT (Figure 5D). In
addition, Stat3YF significantly increased the number of
TUJ1-positive cells (63.4% ± 9% versus 19.2% ± 2%,
p < 0.05, Figures 5E and 5F) and neurite length (147.2
± 20.3 mm versus 75.8 ± 6.9 mm, p < 0.05, Figures 5E and
5G), whereas it decreased the number of GFAP-positive
cells (18.8% ± 1.2% versus 52.5% ± 10.1%, Figures 5E and
5F) when compared with Stat3WT with bFGF removal.
Consistent with these results, Stat3YF markedly enhanced
expression levels of Nt3, Nt4/5, Bdnf, Neuro-D, and Ngn1
by withdrawal of bFGF when compared with the Stat3WTbFGF/vector control. **p < 0.05 compared with the bFGF/vector
r and allowed to differentiate for 1 day. Proteins were analyzed by
nti-GFAP, and anti-GAPDH. *p < 0.05 compared with the bFGF/
coil domain; DBD, DNA-binding domain; LK, linker domain; SH2, Src
Cs for 48 hr, and the cells were induced to differentiate for 2 days.
Y705), anti-STAT3, anti-TUJ1, anti-GFAP, and anti-GAPDH.
er differentiation for 3 days, cells were stained for neuronal (TUJ1,
w the percentages of TUJ1- and GFAP-positive cells. Data are shown
p < 0.05 (for TUJ1). ySignificantly different frombFGF/Stat3WT at
east three slides of each condition. *p < 0.05 compared withbFGF/
SCV-IRES-EGFP-Hpca-Myc were transiently transfected with Stat3WT
Levels of TUJ1 and GFAP were determined by western blotting. Data
or 3 days. Cells were stained for immunocytochemical analysis of
, 10 mm. Graphs show the percentages of TUJ1- and GFAP-positive
from bFGF/Stat3WT/Hpca at p < 0.05 (for TUJ1). ySignificantly
east three slides of each condition. *p < 0.05 compared withbFGF/
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Figure 6. Dephosphorylation of STAT3(Y705) by SHP-1 Is Related to the Neuronal Differentiation of NSCs
(A) NSCs were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-Hpca-Myc for 48 hr before pretreatment with 1 mM PTPI(1) for
30 min. Cells were then allowed to differentiate for 1 day before lysis and analysis by western blotting with anti-p-STAT3(Y705),
anti-STAT3, anti-TUJ1, anti-GFAP, anti-MYC, and anti-GAPDH. *p < 0.05 compared with bFGF/Hpca (mean ± SD; n = 3).
(legend continued on next page)
104 Stem Cell Reports j Vol. 8 j 95–111 j January 10, 2017
(Figure S4). These results indicate that inhibition of
STAT3(Y705) activity promotes neuronal differentiation
accompanied by suppressed astrocytic differentiation.
Next, we asked whether p-STAT3(Y705) played a role
in HPCA-mediated neuronal differentiation in NSCs.
Hpca-induced TUJ1 expression was increased by Stat3YF,
while GFAP expression was significantly decreased when
compared with Stat3WT with bFGF removal (Figure 5H).
In addition, Stat3YF increased Hpca-induced TUJ1-positive
cells (55.4% ± 9% versus 18.3% ± 1.2%, p < 0.05, Figures 5I
and 5J) and neurite length (178.6 ± 11.3 mm versus 101.2 ±
18 mm, p < 0.05, Figures 5I and 5K) compared with
Stat3WT/Hpca with bFGF removal. By contrast, Stat3YF
decreased GFAP-positive cells (14.9% ± 2% versus 32.2%
± 2%, p < 0.05, Figures 5I and 5J) compared with Stat3WT
with bFGF removal in Hpca-transduced cells. These results
suggest that p-STAT3(Y705) inhibits Hpca-induced
neuronal differentiation, leading to astrocyte differentia-
tion in NSCs.
SHP-1 Is Essential for NeuronalDifferentiation ofNSCs
Protein tyrosine phosphatases, such as SHP-1, SHP-2, and
PTP-1B, negatively regulate STAT3 signaling through direct
dephosphorylation of p-STAT3(Y705) (Pandey et al., 2010;
Witkiewicz et al., 2007). Thus, the activity of protein tyro-
sine phosphatases may be critical for the regulation of
STAT3 phosphorylation in NSCs. SHP-1 is a negative regu-
lator of p-STAT3(Y705) (Chen et al., 2012). Therefore, we
examined the participation of SHP-1 in dephosphorylation
of p-STAT3(Y705) during neuronal differentiation in NSCs.
First, we showed that PTPI(1), an inhibitor of SHP-1,
increased STAT3(Y705) phosphorylation and GFAP expres-
sion, while TUJ1 expression decreased (Figures 6A and S5)
in Hpca-induced NSCs during differentiation. Transloca-
tion of STAT3 to the nucleus from the cytosol is known
to reflect STAT3 activation (Ihle, 2001). Therefore, we deter-
mined whether SHP-1 affected the translocation of STAT3
to the nucleus during neuronal differentiation. We found
that PTPI(1) indeed enhanced its translocation to the nu-(B) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP
before differentiation for 1 day. Fixed cells were immunostained with
Arrows indicate magnified cells. Graphs show the ratio of STAT3 nucl
condition. *p < 0.05 compared with bFGF/Hpca (mean ± SD; n = 3)
(C and D) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IR
30 min. After differentiation for 3 days, cells were analyzed immunoc
red) markers. Scale bar, 50 mm. Graphs show the percentages of TUJ
*Significantly different from bFGF/Hpca at p < 0.05 (for TUJ1). ySig
(E) Cells were transfected with control siRNA or Shp-1 siRNA for 48 h
western blotting with anti-p-STAT3(Y705), anti-STAT3, anti-SHP-1, a
(mean ± SD; n = 3).
(F) Cells were transfected with pMSCV-IRES-EGFP or pMSCV-IRES-EGFP-
immunoprecipitates from the cell lysates were analyzed by western bcleus (Figure 6B), indicating that SHP-1 is sufficient to
reduce STAT3 activation, most likely by lowering nuclear
STAT3. Furthermore, the number of TUJ1-positive cells
was decreased by PTPI(1), whereas the number of GFAP-
positive cells was increased (Figures 6C and 6D), indicating
that HPCA-mediated SHP-1 activation is critical for
neuronal differentiation by promoting neurogenesis and
inhibiting gliogenesis. In addition, the role of SHP-1 in
STAT3 activation was confirmed in a Shp-1 knockdown
study. Shp-1 siRNA abolished dephosphorylation of
p-STAT3(Y705), suggesting a crucial role of SHP-1 in
STAT3(Y705) phosphorylation (Figure 6E). We also found
that SHP-1 bound to p-STAT3(Y705) during differentiation,
and that this binding was promoted by Hpca (Figure 6F).
This suggests that HPCA promotes the formation of an
SHP-1/p-STAT3(Y705) complex, leading to dephosphoryla-
tion of p-STAT3(Y705) during neuronal differentiation.
Activation of SHP-1 by acidic phospholipids such as
PA may help to regulate SHP-1 activity (Frank et al.,
1999). PA is the functional enzymatic product of PLD activ-
ity (Exton, 2002). As SHP-1 activity can be influenced by
tyrosine phosphorylation, we determined whether tyro-
sine phosphorylation of SHP-1 is regulated by PA. Exoge-
nously added PA induced phosphorylation of SHP-1 and
dephosphorylation of STAT3 in a dose-dependent manner
(Figure 7A). We next determined whether PLD1, the major
source of PA, affects SHP-1 phosphorylation. Pld1 knock-
down inhibited SHP-1 phosphorylation (Figure 7B), and
Pld1 siRNA affected dephosphorylation of STAT3 (Fig-
ure S6). These results suggest that SHP-1/STAT3 activation
is regulated by PLD1 activation. We further showed that
phosphorylation of SHP-1 was decreased by Hpca knock-
down (Figure 7C). In addition, silencing Hpca or Pld1
with siRNA decreased SHP-1 phosphatase activity (Fig-
ure 7D), as expected.
To confirm the role of SHP-1 in neuronal differentiation,
we knocked down Shp-1, which decreased TUJ1-positive
cells, increased GFAP-positive cells (Figures 7E and 7F),
and significantly reduced neurite length compared with-Hpca-Myc for 48 hr and then treated with 1 mM PTPI(1) for 30 min
anti-STAT3 (red) and anti-DAPI (blue); STAT3 nuclei were counted.
ei to total nuclei in random areas from at least three slides of each
.
ES-EGFP-Hpca-Myc for 48 hr and pretreated with 1 mM PTPI(1) for
ytochemically using neuronal (TUJ1, green) and astrocytic (GFAP,
1- and GFAP-positive cells. Data are shown as mean ± SD (n = 3).
nificantly different from bFGF/Hpca at p < 0.05 (for GFAP).
r and allowed to differentiate for 1 day. Proteins were analyzed by
nd anti-GAPDH. *p < 0.05 compared with the bFGF/control siRNA
Hpca-Myc for 48 hr and induced to differentiate for 24 hr. Anti-SHP-1
lotting with anti-STAT3, anti-p-STAT3, anti-SHP-1, and anti-MYC.
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control siRNA (24.5 ± 6 mm versus 103.2 ± 8 mm, p < 0.05)
(Figure 7G). Furthermore, the number of dendritic spines
was greatly decreased by Shp-1 siRNA (Figure 7H). These re-
sults confirm that SHP-1 is an important regulator of
neurogenesis.DISCUSSION
In the present study, we have shown that HPCA is an
important regulator of the neuronal differentiation of
NSCs and that it promotes neurogenesis and inhibits glio-
genesis. HPCA expression markedly increased during
differentiation of NSCs isolated from the cerebral cortex
in the E14 rat brain. In addition, neurite outgrowth was
enhanced by overexpression of Hpca, indicating that
HPCA could be an important player in neuronal differenti-
ation in the brain. Studies of the signal transduction path-
ways that lead to neuronal differentiation have been
impeded by limitations in the genetic manipulation and
biochemical analysis of primary neuronal cells, including
NSCs. Nevertheless, we have identified a mechanism of
HPCA action that promotes neurogenesis. HPCA recruits
PKCa to PDK1, which facilitates the PKCa-regulated kinase
cascade; PKCa-dependent PLD1 activation is required for
HPCA-mediated neurite outgrowth. PA, a functional prod-
uct of PLD1, affects tyrosine phosphatase SHP-1 activation
during neuronal differentiation, and SHP-1 blocks
STAT3(Y705) activation, thereby inhibiting gliogenesis in
NSCs (Figure 7I). Thus, this signaling pathway providesFigure 7. SHP-1 Is Required for Neuronal Differentiation of NSCs
(A) NSCs were treated with 10 mM or 20 mM phosphatidic acid (PA) for
blotting with anti-p-SHP-1, anti-SHP-1, anti-p-STAT3(Y705), anti-ST
(B) Cells were transfected with control siRNA or Pld1 siRNA for 48 hr
western blotting with anti-p-SHP1 (Y536), anti-SHP-1, anti-PLD1, an
(mean ± SD; n = 3).
(C) Cells were transfected with control siRNA or Hpca siRNA for 48 hr a
western blotting with anti-p-SHP1 (Y536), anti-SHP-1, anti-HPCA, an
(mean ± SD; n = 3).
(D) Cells were transfected with control siRNA, Hpca siRNA, or Pld1 siRN
measured by phosphatase activity assay (see Experimental Procedure
n = 5).
(E and F) Cells were transfected with control siRNA or Shp-1 siRNA
immunostained with anti-TUJ1 and anti-GFAP, and TUJ1- and GFAP
percentages of TUJ1- and GFAP-positive cells. Data are shown as mean
p < 0.05 (for TUJ1). ySignificantly different from bFGF/control siRN
(G) Neurite lengths were measured in randomly selected areas from a
bFGF/control siRNA (mean ± SD; n = 3).
(H) Cells were transfected with control siRNA or Shp-1 siRNA for 48 h
entiation for 3 days, fixed cells were immunostained with anti-TUJ1.
counted in randomly selected areas from at least three slides of each c
± SD; n = 3).
(I) The model suggests that HPCA plays a crucial role in neurogene
pathway.insight into HPCA-mediated neuronal function in rat
NSCs and its potential contribution to cell-fate signaling.
HPCA Promotes Neurogenesis by Inhibiting
Gliogenesis
The specification of cell fate involves the commutative acti-
vation of genes related to a particular cell fate and the inhi-
bition of genes related to alternative fates. Cell-fate-speci-
fying transcription factors can both positively and
negatively regulate alternative fates (Scully et al., 2000; Taj-
bakhsh et al., 1996), and a recent study reported thatNGN1
has dual functions in activating neuronal differentiation
genes and suppressing glial differentiation genes (Sun
et al., 2001). Similarly, our study suggests that HPCA posi-
tively regulates neurogenesis and negatively regulates glio-
genesis in NSCs. This is supported by our findings that: (1)
knockdown of Hpca strongly decreased neurite outgrowth
and dendritic spinogenesis, whereas it increased expression
of the astrocyte marker GFAP and GFAP-positive cells; and
(2) overexpression of Hpca significantly stimulated neurite
outgrowth and expression of the neuron marker TUJ1,
even in the presence of bFGF. These results are consistent
with the concept that a specific gene product such as
Ngn-1 inhibits glial differentiation (Nieto et al., 2001).
The Role of HPCA in PKCa/PLD1 Activation during
Neuronal Differentiation
HPCA has a Ca2+/myristoyl switch, allowing membrane
translocation from the cytosol in response to increased
free Ca2+ concentrations (O’Callaghan et al., 2003). In1 day in the presence of bFGF. Cell lysates were analyzed by western
AT3, and anti-GAPDH.
and allowed to differentiate for 1 day. Proteins were analyzed by
d anti-GAPDH. *p < 0.05 compared with the bFGF/control siRNA
nd allowed to differentiate for 1 day. Cell lysates were analyzed by
d anti-GAPDH. *p < 0.05 compared with the bFGF/control siRNA
A for 48 hr and allowed to differentiate for 1 day. SHP-1 activity was
s). *p < 0.05 compared with the bFGF/control siRNA (mean ± SD;
for 48 hr and allowed to differentiate for 3 days. Fixed cells were
-positive cells were counted. Scale bar, 20 mm. Graphs show the
± SD (n = 5). *Significantly different frombFGF/control siRNA at
A at p < 0.05 (for GFAP).
t least three slides of each condition. *p < 0.05 compared with the
r and induced to differentiate by withdrawal of bFGF. After differ-
Scale bar, 10 mm. The numbers of spines per 10-mm dendrite were
ondition. *p < 0.05 compared with thebFGF/control siRNA (mean
sis through modulation of the PKCa/PLD1/SHP-1/STAT3 signaling
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neurons, HPCA is located in the cytoplasm and plasma
membrane of cell bodies, dendrites, and axons (Burgoyne
et al., 2004). HPCA exerts a neuroprotective action by
blocking the formation of Ca2+-induced cell death stimuli
(Masuo et al., 2007), and infusion of a mutantHpca lacking
Ca2+-binding sites prevents long-term depression in hippo-
campal neurons (Jo et al., 2010). Since HPCA has a crucial
role in Ca2+-mediated neuronal activity in the brain, we
investigated its potential role in Ca2+-dependent signaling
pathways in NSCs. When cells were induced to differen-
tiate by removal of bFGF, Ca2+ levels increased and HPCA
translocated to the membrane. Furthermore, HPCA assis-
ted the formation of a PDK1-PKCa complex, which induces
PKCa phosphorylation. As summarized in Figure 7I, it is
not known whether HPCA has direct or indirect effects
on PDK1 activation or binds to PDK1.Moreover, themolec-
ular mechanism responsible for the phosphorylation of
PDK1 by differentiation stimulus has not yet been defined.
Thus, further studies are needed to clarify the relationship
between HPCA and PDK1 signaling during neuronal differ-
entiation in NSCs; this could be important for a complete
understanding of HPCA-mediated signaling cascade in
neurogenesis of NSCs. Our previous studies showed that
HPCA played a role in Ca2+-dependent PLD activation
(Hyun et al., 2000), and PLD1 promotes neurite outgrowth
in H19-7 cells (Yoon et al., 2012). As expected, PLD1 is
involved in HPCA-mediated neurogenesis and its activa-
tion is regulated by HPCA. Taken together, our results
suggest that HPCA is required for optimal formation of a
complex between PDK1 and PKCa, resulting in PLD1 acti-
vation during neuronal differentiation.
Blocking of STAT3(Y705) Activation by HPCA
Increases Neuronal Differentiation and Decreases
Astrocytic Differentiation of NSCs
STAT3 plays essential roles in determining the fate of NSCs
(Cao et al., 2010). In the present study, NSC differentiation
induced by removal of bFGF resulted in a dramatic reduc-
tion in the phosphorylation of STAT3(Y705). Interestingly,
HPCA’s inhibition of STAT3(Y705) phosphorylation
induced neurogenesis and decreased gliogenesis. Further-
more, Stat3YFmutant significantly promotesHpca-induced
TUJ1 expression and TUJ1-positive cells, while it failed to
stimulate GFAP expression and GFAP-positive cells. Our re-
sults are consistent with earlier reports in which suppres-
sion or conditional deletion of Stat3 promotes neuronal dif-
ferentiation and inhibits glial differentiation (Gu et al.,
2005; Natarajan et al., 2014). The activities of intracellular
transcription factors are controlled by the competing activ-
ities of kinases and phosphatases (Massa et al., 2004). We
found that SHP-1 led to loss of STAT3(Y705) activation.
Interestingly, SHP-1 binds to phosphorylated STAT3(Y705)
under differentiation conditions and this process was pro-108 Stem Cell Reports j Vol. 8 j 95–111 j January 10, 2017moted by HPCA. Thus, we conclude that HPCA-mediated
SHP-1 activity most likely inhibits STAT3 activity by
blocking its import to the nucleus and, presumably, by
decreasing the nuclear accumulation of phosphorylated
STAT3(Y705), resulting in increased neurogenesis.
In summary, HPCA appears to have two distinct roles:
promoting neurogenesis and inhibiting gliogenesis. We
propose that it has an important role in enhancing the gen-
eration of neurons from NSCs. Neurogenesis is tightly
controlled because of its critical importance in proper phys-
iological function, and multiple signals control the growth
and directionality of the relevant cell-fate decision. Howev-
er, the mechanism by which HPCA affects Ca2+-dependent
signaling during neurogenesis remains to be determined,
and a more detailed characterization of the mechanisms
is currently under way. HPCA may be implicated in mem-
ory formation, neuronal excitability, and activity-depen-
dent plasticity (Kobayashi et al., 2012). Hpca knockout
(Hpca/) mice have a defect in CREB activation that is
associated with impaired spatial and associative memory
(Kobayashi et al., 2005) as well as an impaired RAS-regu-
lated kinase cascade in response to RAF activation (Noguchi
et al., 2007). It is possible that HPCA plays an important
role in long-lasting neural plasticity and promotes spatial
and associative memory. Nevertheless, despite recent prog-
ress, much remains unknown regarding the contribution
of HPCA-mediated signaling mechanisms to brain injury
and recovery. Further studies are required to address its
possible use as a marker of neurodegenerative disorders
and in promoting neuronal regeneration in vivo.EXPERIMENTAL PROCEDURES
Preparation of Animal Tissue
All experimental animal procedures (Sprague-Dawley rats) were
approved by the Institutional Animal Care and Use Committee
(IACUC) at Hanyang College of Medicine under approval number
2015-0009. Experiments were performed in accordance with the
NIH guidelines.Primary Culture of Neural Precursor Cells
Embryonic brain cortices from E14 rat embryos weremechanically
triturated in Ca2+/Mg2+-free Hank’s balanced salt solution (HBSS;
Gibco), seeded at 2 3 105 cells in 10-cm culture dishes (Corning
Life Sciences), which were precoated with 15 mg/mL poly-L-orni-
thine (Sigma) and 1 mg/mL fibronectin (Invitrogen) and then
cultured for 5–6 days in serum-free N2 medium supplemented
with 20 ng/mL bFGF (R&D Systems). Cell clusters generated by
precursor cell proliferation were dissociated in HBSS and plated
at 2 3 104 cells per well on coated 24-well plates, 2 3 105 cells
per well on coated 6-well plates, and 8 3 105 cells per dish on
coated 6-cm culture dishes. The plated cells were allowed to prolif-
erate further in N2 + bFGF up to 70%–80% cell confluence before
induction of differentiation. All experiments were carried out us-
ing the passage 1 (P1) neural precursor cells.
Other Procedures
Full additional information is available in Supplemental Experi-
mental Procedures.
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Procedures and six figures and can be foundwith this article online
at http://dx.doi.org/10.1016/j.stemcr.2016.11.009.
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